vimarsana.com
Home
Live Updates
Vaxxas Awarded US$3.67 million (AU$5.4 million) from global
Vaxxas Awarded US$3.67 million (AU$5.4 million) from global
Vaxxas Awarded US$3.67 million (AU$5.4 million) from global charitable foundation, Wellcome, for Human Clinical Study of Typhoid Vaccination using Needle-Free Vaccine Patch
CAMBRIDGE, Mass. & BRISBANE, Queensland, Australia--(BUSINESS WIRE)--Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced that the global
Related Keywords
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Brisbane ,
Queensland ,
Australia ,
United States ,
Australian ,
Gyun Kim ,
Kathryn Morris ,
Jeannies Pak ,
Changhyun Jin ,
Davidl Hoey ,
Pierre Balard ,
Amy Miller ,
Jaeyong Ahn ,
World Health Organization ,
International Vaccine Institute ,
Oneventures Innovation Fund ,
University Of Queensland ,
Wellcome ,
Wellcome Media Office ,
Development Authority ,
Communications Team ,
Senior Research ,
Australian Government Innovation Investment Fund ,
Yates Network ,
Melinda Gates Foundation ,
United States Biomedical Advanced Research ,
Salmonella Typhi ,
Senior Research Manager ,
Melinda Gates ,
Drug Safety ,
Brandon Capital Partners ,
Healthcare Ventures ,
Brandon Biocatalyst ,
Australian Government ,
Innovation Investment Fund ,
Media Office ,
Press Release ,
,